Showing results (1381-1390 of 3,660) with videos related to
Sort By:
Pageof 366
Breast (Edinburgh, Scotland)|May 21, 2011
The prognostic significance of computerised tomography findings in women with liver metastases from breast cancerJ C Mhlanga, A E Evans, S Doyle, et al.Breast (Edinburgh, Scotland)|May 21, 2011
Renin angiotensin system-regulating aminopeptidase activities in serum of pre- and postmenopausal women with breast cancerJosé Manuel Martínez-Martos, María del Pilar Carrera-González, Basilio Dueñas, et al.Breast (Edinburgh, Scotland)|June 7, 2011
Intraductal papillomas of the breast: diagnosis and management of 151 patientsChristiane Richter-Ehrenstein, Felicia Tombokan, Eva-Maria Fallenberg, et al.Breast (Edinburgh, Scotland)|February 21, 2012
Factors associated with long-term functional outcomes and psychological sequelae in women after breast cancerFary Khan, Bhasker Amatya, Julie F Pallant, et al.Breast (Edinburgh, Scotland)|November 29, 2011
The effect of introducing an in-theatre intra-operative specimen radiography (IOSR) system on the management of palpable breast cancer within a single unitD M Layfield, D J May, R I Cutress, et al.Breast (Edinburgh, Scotland)|November 29, 2011
Predictive value of peripheral blood lymphocyte count in breast cancer patients treated with primary chemotherapyMaria Angeles Vicente Conesa, Elena Garcia-Martinez, Enrique Gonzalez Billalabeitia, et al.Breast (Edinburgh, Scotland)|October 7, 2011
Influence of catechol-o-methyltransferase genotype (Val158Met) on endocrine, sympathetic nervous and mucosal immune systems in breast cancer survivorsCésar Fernández-de-Las-Peñas, Irene Cantarero-Villanueva, Carolina Fernández-Lao, et al.Breast (Edinburgh, Scotland)|October 22, 2011
Intraoperative radiation therapy: is it a standard now?Roberto Orecchia, Maria Cristina LeonardoBreast (Edinburgh, Scotland)|October 22, 2011
PARP inhibitors--current status and the walk towards early breast cancerJennifer Glendenning, Andrew TuttBreast (Edinburgh, Scotland)|October 22, 2011
Is there a case for anti-HER2 therapy without chemotherapy in early breast cancer?Anastasia Constantinidou, Ian SmithPageof 366